10 Worst ARK Stocks To Buy According to Short Sellers
Cathie Wood of ARK Investment is one of Wall Street's most well-known hedge fund bosses.
Crispr Therapeutics Ag (CRSP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 7,498,625 | $352,285,403 | -4% | 3.22% |
| 2. | EcoR1 Capital Oleg Nodelman | 1,389,276 | $65,268,186 | 2.23% | |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 843,075 | $39,607,664 | +744% | 0.41% |
| 4. | 695,400 | $32,669,892 | -3% | 0% | |
| 5. | Balyasny Asset Management Dmitry Balyasny | 623,650 | $29,299,077 | +588% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.95 | 27,461 | Large Shareholder | 5,380,940 | 2018-12-27 | Filing | |
| $24.89 | 12,737 | Large Shareholder | 5,353,479 | 2018-12-26 | Filing | |
| $24.97 | 53,655 | Large Shareholder | 5,340,742 | 2018-12-24 | Filing | |
| $23.18 | 11,742 | Large Shareholder | 5,287,087 | 2018-12-24 | Filing | |
| $22.91 | 2,603 | Large Shareholder | 5,275,345 | 2018-12-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.10 | 15,000 | 181,540 | 2024-12-02 | Filing | ||
| $56.27 | 6,879 | 196,540 | 2024-11-11 | Filing | ||
| $55.43 | 23,121 | 203,419 | 2024-11-11 | Filing | ||
| $46.28 | 1,089 | 62,597 | 2024-10-14 | Filing | ||
| $46.28 | 4,293 | 226,540 | 2024-10-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,134,450 | $384,016,570 | 0.08% | |
| 2. | 3,369,762 | $210,947,101 | 0.15% | |
| 3. | 3,369,762 | $210,913,404 | 2.02% | |
| 4. | 2,516,486 | $157,532,022 | 0% | |
| 5. | 1,839,871 | $115,175,906 | 0% |
News See All
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
ARK Invest Stock Portfolio: Top 10 Stock Picks for 2024
ARK Investment Management LLC, more commonly known as ARK Invest, is an American investment management firm headquartered in St. Petersburg, Florida, that oversees several actively managed ETFs.
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds
The pharmaceutical industry remains a hub of patent innovation, driven by evolving treatment paradigms, unmet medical needs, and the rising influence of technologies like pharmacogenomics, digital therapeutics...
10 Most Promising Biotech Stocks According to Hedge Funds
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
10 Worst ARK Stocks To Buy According To Short Sellers
Investing comes in all sizes and flavors. For the risk averse investors that are looking for steady payouts or long term stability, value and dividend paying stocks are the way to go.
Ark Invest Stock Portfolio: Top 10 Picks
If there's one thing that can be said for sure, it's that Cathie Wood's investment approach is one of the most unique on Wall Street.
10 Best Stocks to Buy and Hold For 5 Years According to Cathie Wood
As the saying goes, time and tide wait for nobody. This also holds true for Wall Street, where not only are fortunes made in a blink of an eye, but things can take a 180 degree turn the next moment.
15 Best ARK Stocks To Buy Now
Cathie Wood is one of the most polarizing, and prominent figures on Wall Street.
Billionaire Hedge Funds
